Clinical Trial Update: National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

View source ↗

Summary

Clinical trial update on a precision-based immunotherapy program for primary liver cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma
• Liver Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hepatocellular Carcinoma, Liver Cancer | Status: ACTIVE_NOT_RECRUITING